VivoSeq
Other

Oxidative Stress

116

Pipeline Programs

11

Active Trials

39

Companies Involved

Oxidative Stress is a highly competitive landscape with 116 programs across 39 companies. The most active players are Tonghua Anrate Biopharmaceutical Co., Ltd., Applied Therapeutics, Inc., AbbVie. 35 therapies are approved with 16 more in late-stage development.

Pipeline Metrics

Competitive Density

72/100

Pipeline Velocity

27/100

Mech. Concentration

7/100

Completion Rate

90/100

Attrition Rate

6/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Modality Breakdown

97%

Small molecule

125 of 129 classified programs — the dominant modality here.

3%ALL OTHERSProtein / enzyme22%Vaccine22%

Small molecule leads; the ring shows all 129 classified programs, each share of the total. Modality classified for 100% of 139 pipeline programs.

Trial Status

114

clinical trials

Completed66 · 58%
Unknown status30 · 26%
Recruiting7 · 6%
Terminated6 · 5%
Enrolling by invitation2 · 2%
Active, not recruiting2 · 2%
Other1 · 1%

Trial Activity

114 trials

Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers
Active, not recruiting··Phase 2·NCT02994069·80 enrolled
Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers
Active, not recruiting··N/A·NCT00682318·40 enrolled
Page 1 of 8

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)